Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells

Diabetes - United States
doi 10.2337/db13-1042
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

F2-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: A Review

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2009English

Biomarkers in Type 2 Diabetes

International Journal of Diabetes & Metabolic Disorders
2018English

Insulin for Type 2 Diabetes: Choosing a Second-Line Insulin Regimen

International Journal of Clinical Practice
Medicine
2008English

Cardiovascular Safety of Non-Insulin Pharmacotherapy for Type 2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2017English

Candidate Biomarkers for Type 1 Diabetes

Journal of Proteome Research
BiochemistryChemistry
2008English

Cardiovascular Disease Biomarkers Are Associated With Declining Renal Function in Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Intensive Insulin Therapy as the Primary Treatment for Type 2 Diabetes

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Protein Biomarkers for the Prediction of Cardiovascular Disease in Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Circulating microRNAs as Novel Biomarkers for Diabetes Mellitus

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy